Daniel Wolterman - Invuity Director

Director

Mr. Daniel J. Wolterman is appointed as Director of the company effective as of September 5, 2017. He previously served as President and CEO of Memorial Hermann Health System, the largest notforprofit health system in Southeast Texas, from 2002 until his retirement in 2016. He has more than 30 years of experience in the healthcare industry and a long history of community involvement. He currently serves as a member of the boards of directors of NuVasive, Inc., Legacy ER Urgent Care, and Vizient, Inc. He previously served on the board of directors of Volcano Corporation prior to its acquisition by Royal Philips in February 2015. Currently, Mr. Wolterman is sole owner and CEO of Wolterman Consulting, LLC. Wolterman Consulting, LLC provides strategic and operational consulting services to healthcare providers and other entities. Mr. Wolterman earned a B.S. degree in business administration and a M.B.A. in finance from the University of Cincinnati and a Masters Degree in healthcare administration from Xavier University. Mr. Woltermans extensive knowledge of the healthcare industry and his executive leadership experience as President and CEO of Memorial Hermann Health System provide valuable perspective and guidance to the Board. since 2017.
Age 60
Tenure 7 years
Phone415-665-2100
Webhttp://www.invuity.com

Invuity Management Efficiency

The company has return on total asset (ROA) of (39.66) % which means that it has lost $39.66 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (481.4) %, meaning that it created substantial loss on money invested by shareholders. Invuity's management efficiency ratios could be used to measure how well Invuity manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 34.66 M in liabilities. Invuity has a current ratio of 2.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Invuity until it has trouble settling it off, either with new capital or with free cash flow. So, Invuity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Invuity sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Invuity to invest in growth at high rates of return. When we think about Invuity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Barbara TysonTyson Foods
71
Kurt LandgrafCorning Incorporated
74
Kimberly PlaskettCECO Environmental Corp
N/A
Robert ThurberTyson Foods
72
Richard VaughnInsteel Industries
75
Wu SunPOSCO Holdings
61
Marcia SantosMarfrig Global Foods
N/A
Kevin MartinCorning Incorporated
54
Donald BlairCorning Incorporated
62
Roberto FaldiniMarfrig Global Foods
69
Abney BoxleyInsteel Industries
62
Jose MironMarfrig Global Foods
52
Antonio MacielMarfrig Global Foods
N/A
Anne LloydInsteel Industries
59
Carlos LangoniMarfrig Global Foods
73
Leslie ThorntonCECO Environmental Corp
59
Robert CummingsCorning Incorporated
71
Brad SauerTyson Foods
55
Thomas LallyCECO Environmental Corp
74
Gregory JacksonCECO Environmental Corp
51
Louis HannenInsteel Industries
76
Invuity, Inc., a medical technology company, develops and markets surgical devices in the United States and Asia. Invuity, Inc. was incorporated in 2004 and is based in San Francisco, California. Invuity operates under Medical Instruments Supplies classification in USA and is traded on NASDAQ General Markets. It employs 161 people. Invuity (IVTY) is traded on NASDAQ Exchange in USA and employs 161 people.

Management Performance

Invuity Leadership Team

Elected by the shareholders, the Invuity's board of directors comprises two types of representatives: Invuity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Invuity. The board's role is to monitor Invuity's management team and ensure that shareholders' interests are well served. Invuity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Invuity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Gerberich, Vice President - Sales and Marketing
Douglas Heigel, VP of Operations
Daniel Wolterman, Director
Alex Vayser, Co-Founder and CTO
William Burke, Independent Director
Philip Sawyer, CEO and President and Director
Eric Roberts, Independent Director
Andrew Sale, Senior Vice President of Global Sales
Scott Flora, Director
Gregory Brown,
James Mackaness, CFO
Steve Annen, Vice President of Product Management and Strategy
Joseph Guido, Vice President of Business Development
Randall Lipps, Independent Director
Paul Davison, VP of RandD
Reza Zadno, Independent Director
Brett Robertson, Chief Business Officer, General Counsel
Gregory Lucier, Chairman of the Board
Marcia Fish, Chief Human Resource Officer

Invuity Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Invuity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Invuity Stock

If you are still planning to invest in Invuity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Invuity's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine